Study reassures patients about semaglutide safety

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania published this week in JAMA Internal Medicine.

Berkeley Officially Decriminalizes Possession of Psilocybin Mushrooms and Ayahuasca | Psychedelic Spotlight

Berkeley has long been an epicenter of psychedelic research and culture in the United States. In particular, UC Berkeley alumni Terence McKenna, a philosopher and ethnobotanist,

July 12, 2023

Eating disorder and self-harm diagnosis surged during the COVID-19 pandemic: an urgent need for intervention

Researchers examined incidence rates of eating disorders and self-harm after the COVID-19 pandemic.

June 23, 2023

Research shows mechanistic link between amino acid transport and common fetal conditions

Common complications of pregnancy affecting fetal size may be caused by irregularities in the transport of amino acids across the placenta-;a finding with therapeutic implications.

June 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.